CVS Health Corporation (CVS)
| Previous close | 55.15 |
| Open | 55.22 |
| Bid | 55.17 x 1100 |
| Ask | 55.19 x 800 |
| Day's range | 54.96 - 55.55 |
| 52-week range | 53.70 - 83.25 |
| Volume | |
| Avg. volume | 10,744,558 |
| Market cap | 69.215B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.67 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.66 (4.82%) |
| Ex-dividend date | 19 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE
CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2024.
- PR Newswire
CVS Health opens new workforce development and community resource center in Baton Rouge
CVS Health® (NYSE: CVS) today announced the opening of a new workforce development and community resource center designed to help the Baton Rouge community overcome employment barriers and increase access to local health care services.
- PR Newswire
CVS Health invests $19.2 million in affordable housing in Arvada, Colorado
CVS Health® (NYSE: CVS) today announced it has invested $19.2 million through Boston Financial to build 85 new affordable housing units in Arvada, Colorado. Made possible through the company's collaboration with Family Tree and BlueLine Development, the investment demonstrates CVS Health's commitment to improving the health of individuals across the country, which begins with providing access to quality, safe, affordable housing, especially in historically underserved communities.
